Cigna will add Humira biosimilars to its pharmacy formulary, giving the new, cheaper alternative products hitting the market next year the same position as the drug.
Payer Policy Updates
New Jersey is likely to soon become the eighth state to require state-regulated health plans to cover abortion services, Bloomberg reported Dec. 1.
The Connected Health Initiative, a coalition of medical groups, payers, universities and technology companies, wrote to congressional leaders Nov. 28 urging them to extend telehealth coverage for people with high deductible health plans before they hit their deductible, a policy…
Nearly 3.4 million people have signed up for ACA coverage since the open enrollment period began Nov. 1, or a 17 percent increase in enrollment since last year.
Sen. Bernie Sanders' office said Nov. 17 that he is looking to become chair of the Senate's Health, Education, Labor and Pensions Committee, according to The Hill.
Advertisement
The expiration of the federal COVID-19 public health emergency will trigger a nationwide Medicaid redetermination process, but most Medicaid members are unaware their health coverage could eventually end — and payers largely aren't getting the word out.
UnitedHealth Group's OptumRx will keep Humira in its drug formulary, in addition to three biosimilar competitors, Bloomberg reported Nov. 15.
U.S. Senate Democrats are urging CMS to continue its oversight of Medicare Advantage marketing practices and introduce additional regulations to protect consumers from deceptive tactics.
Newly capped insulin prices for Medicare beneficiaries at $35 won't show up in Medicare Plan Finder this year.
The U.S. will extend the COVID-19 public health emergency past January 11, 2023, CNBC reported Nov. 11.